Black Rock Inc. Amarin Corp Plcuk Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Black Rock Inc. holds 270,064 shares of AMRN stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

270,064

Previous 249,710 8.15%

Holding current value

$4.02 Million

Previous $222,000 16.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.63 - $1.07 $12,823 - $21,778	20,354 Added 8.15%	270,064 $186,000
Q1 2024 May 10, 2024	BUY	$0.82 - $1.35 $41,533 - $68,377	50,650 Added 25.44%	249,710 $222,000
Q4 2023 Feb 13, 2024	SELL	$0.66 - $0.91 $17,821 - $24,572	-27,003 Reduced 11.94%	199,060 $173,000
Q3 2023 Nov 13, 2023	SELL	$0.85 - $1.43 $45,078 - $75,837	-53,033 Reduced 19.0%	226,063 $207,000
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.49 $25,226 - $33,560	-22,524 Reduced 7.47%	279,096 $332,000
Q1 2023 May 12, 2023	SELL	$1.19 - $2.19 $20,791 - $38,263	-17,472 Reduced 5.48%	301,620 $452,000
Q4 2022 Feb 13, 2023	SELL	$1.07 - $1.34 $43,521 - $54,503	-40,674 Reduced 11.31%	319,092 $386,000
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $95,783 - $146,751	87,875 Added 32.32%	359,766 $392,000
Q2 2022 Aug 12, 2022	BUY	$1.13 - $3.69 $67,432 - $220,200	59,675 Added 28.12%	271,891 $404,000
Q1 2022 May 12, 2022	BUY	$2.85 - $3.73 $21,169 - $27,706	7,428 Added 3.63%	212,216 $698,000
Q4 2021 Feb 10, 2022	BUY	$3.24 - $5.18 $22,748 - $36,368	7,021 Added 3.55%	204,788 $690,000
Q3 2021 Nov 09, 2021	BUY	$3.94 - $5.84 $122,581 - $181,694	31,112 Added 18.67%	197,767 $1.01 Million
Q2 2021 Aug 11, 2021	BUY	$4.26 - $6.5 $709,950 - $1.08 Million	166,655 New	166,655 $730,000

Others Institutions Holding AMRN

# of Institutions

Shares Held

8.33M

Call Options Held

Put Options Held

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.01B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account